ACETO Corp (ACET) Tops Q4 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
ACETO Reports Fiscal 2015 Fourth Quarter and Year End Results
September 10, 2015 5:00 PM EDTPORT WASHINGTON, N.Y., Sept. 10, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the fourth quarter of fiscal 2015 ended June 30, 2015.
Fiscal 2015 versus Fiscal 2014
Net sales of $547.0 million versus $510.2 million, a 7.2% increase Gross profit of $135.4 million versus $114.7 million, an 18.1% increase Net income of $33.5 million versus $29.0 million, a 15.5% increase Diluted EPS of $1.14 versus $1.02, an 11.8% increase Non-GAAP Adjusted Net Income of $38.9 million versus $34.7 million, a 12.0% increase... More